Icarus Medical Raises $7.2 Million to Expand Orthopedic Tech

The financing round drew participation from a diverse group of investors, including Riptide Ventures, OSF Ventures, and the CU Healthcare Innovation Fund. Beyond the capital injection, these partners provide strategic industry expertise intended to help Icarus navigate its next phase of growth. CEO Dave Johnson cited the round as a validation of the company's clinical impact and its ability to scale in a competitive medical technology landscape.

Icarus Medical centers its product line on biomechanics and additive manufacturing, with flagship devices like the Ascender and Adonis knee braces targeting osteoarthritis and complex mobility challenges. The company, which recently reported 1,283% three-year growth and earned the 2026 CBIC Startup of the Year Award, continues to manufacture its hardware in Virginia. Ben Spektor of OSF Ventures noted that clinical validation played a key role in the investment decision, emphasizing the demand for solutions that address significant unmet needs in orthopedic care.